Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2015) |  Total Docs. (3years) |
Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 | Advances in Pharmacological Sciences | journal | 0.749 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |  |
| 173 | Cellular Oncology | journal | 0.495 Q3 | 44 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |  |
| 172 | Cellular Therapy and Transplantation | journal | 8 | 10 | 0 | 200 | 0 | 0 | 0.00 | 20.00 |  | |
| 171 | Current Biomarkers | journal | 0.102 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 170 | Current Molecular Imaging | journal | 2 | 5 | 0 | 346 | 0 | 0 | 0.00 | 69.20 | | |
| 169 | MedChemComm | journal | 0.936 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |  |
| 168 | Current Chemical Genomics | journal | 0.586 Q3 | 16 | 0 | 1 | 0 | 2 | 1 | 0.00 | 0.00 | |
| 167 | International Journal of Medicinal Chemistry | journal | 0.115 Q4 | 4 | 1 | 2 | 22 | 1 | 2 | 0.50 | 22.00 | |
| 166 | Journal of Experimental Pharmacology | journal | 0.323 Q4 | 23 | 4 | 4 | 322 | 9 | 4 | 3.00 | 80.50 |  |
| 165 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | |
| 164 | BMC Chemical Biology | journal | 0.423 Q3 | 21 | 0 | 5 | 0 | 14 | 5 | 0.00 | 0.00 | |
| 163 | Current Chemical Genomics and Translational Medicine | journal | 0.574 Q3 | 9 | 2 | 5 | 43 | 15 | 4 | 3.00 | 21.50 | |
| 162 | Gene Therapy and Regulation | journal | 0.292 Q4 | 7 | 0 | 5 | 0 | 12 | 5 | 0.00 | 0.00 |  |
| 161 | Molecular Therapy - Oncolytics | journal | 0.272 Q4 | 42 | 22 | 6 | 1480 | 4 | 5 | 0.67 | 67.27 | |
| 160 | Genetic Vaccines and Therapy | journal | 0.596 Q3 | 30 | 0 | 9 | 0 | 17 | 9 | 0.00 | 0.00 | |
| 159 | Open Pharmacology Journal | journal | 0.149 Q4 | 6 | 0 | 9 | 0 | 3 | 8 | 0.00 | 0.00 | |
| 158 | Biomolecular Detection and Quantification | journal | 0.995 Q2 | 29 | 14 | 10 | 499 | 23 | 9 | 2.30 | 35.64 | |
| 157 | Recent Patents on Biomarkers | journal | 3 | 13 | 14 | 670 | 0 | 13 | 0.00 | 51.54 | | |
| 156 | Open Medicinal Chemistry Journal | journal | 0.310 Q4 | 23 | 3 | 15 | 116 | 23 | 15 | 1.64 | 38.67 |  |
| 155 | Progress in Medicinal Chemistry | journal | 1.504 Q2 | 38 | 6 | 16 | 705 | 71 | 0 | 5.00 | 117.50 | |
| 154 | Drugs in Context | journal | 0.681 Q3 | 36 | 20 | 23 | 761 | 43 | 21 | 1.65 | 38.05 | |
| 153 | BBA Clinical | journal | 0.475 Q3 | 35 | 56 | 24 | 3144 | 33 | 22 | 1.38 | 56.14 | |
| 152 | Drug Discovery Today: Disease Mechanisms | journal | 0.433 Q3 | 28 | 0 | 27 | 0 | 29 | 24 | 1.44 | 0.00 | |
| 151 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.264 Q4 | 29 | 8 | 35 | 717 | 42 | 0 | 1.59 | 89.63 | |
| 150 | MCB Molecular and Cellular Biomechanics | journal | 0.312 Q4 | 31 | 17 | 43 | 578 | 56 | 43 | 1.26 | 34.00 | |
| 149 | Biomarker Insights | journal | 0.800 Q3 | 40 | 68 | 45 | 5487 | 111 | 44 | 1.83 | 80.69 | |
| 148 | Current Enzyme Inhibition | journal | 0.143 Q4 | 19 | 17 | 46 | 570 | 11 | 40 | 0.24 | 33.53 | |
| 147 | Expert Reviews in Molecular Medicine | journal | 2.176 Q1 | 93 | 21 | 48 | 2631 | 310 | 48 | 6.90 | 125.29 | |
| 146 | Drug Discovery Today: Therapeutic Strategies | journal | 0.337 Q4 | 31 | 0 | 49 | 0 | 37 | 44 | 0.50 | 0.00 | |
| 145 | Pteridines | journal | 0.162 Q4 | 19 | 18 | 50 | 743 | 21 | 49 | 0.39 | 41.28 | |
| 144 | Gene Therapy and Molecular Biology | journal | 0.148 Q4 | 18 | 0 | 55 | 0 | 16 | 55 | 0.21 | 0.00 |  |
| 143 | Journal of Stem Cells | journal | 0.416 Q3 | 21 | 23 | 56 | 700 | 78 | 55 | 1.57 | 30.43 | |
| 142 | Biomarker Research | journal | 48 | 8 | 57 | 358 | 185 | 55 | 3.25 | 44.75 | | |
| 141 | Journal for ImmunoTherapy of Cancer | journal | 1.929 Q1 | 117 | 83 | 63 | 2067 | 318 | 60 | 5.05 | 24.90 | |
| 140 | Pharmacogenomics and Personalized Medicine | journal | 1.195 Q2 | 37 | 15 | 63 | 858 | 275 | 63 | 4.46 | 57.20 | |
| 139 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.195 Q4 | 14 | 29 | 65 | 1633 | 21 | 58 | 0.15 | 56.31 | |
| 138 | VacciMonitor | journal | 0.101 Q4 | 5 | 3 | 65 | 61 | 6 | 61 | 0.07 | 20.33 |  |
| 137 | Analytical Cellular Pathology | journal | 0.354 Q4 | 35 | 42 | 66 | 2353 | 73 | 63 | 0.93 | 56.02 |  |
| 136 | Molecular Therapy - Methods and Clinical Development | journal | 0.827 Q3 | 60 | 59 | 67 | 2371 | 124 | 65 | 1.85 | 40.19 | |
| 135 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.506 Q3 | 39 | 25 | 69 | 964 | 124 | 61 | 1.66 | 38.56 | |
| 134 | Human Genomics | journal | 1.598 Q2 | 68 | 31 | 71 | 1471 | 250 | 68 | 3.64 | 47.45 | |
| 133 | Current Molecular Pharmacology | journal | 1.354 Q2 | 49 | 35 | 77 | 3169 | 231 | 67 | 2.03 | 90.54 | |
| 132 | Molecular and Cellular Oncology | journal | 37 | 151 | 78 | 4346 | 20 | 71 | 0.26 | 28.78 | | |
| 131 | Clinical Proteomics | journal | 1.223 Q2 | 42 | 29 | 79 | 1453 | 306 | 79 | 3.83 | 50.10 | |
| 130 | Nucleus (India) | journal | 0.243 Q4 | 17 | 33 | 79 | 919 | 50 | 77 | 0.58 | 27.85 |  |
| 129 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.760 Q3 | 45 | 28 | 82 | 1689 | 154 | 76 | 1.81 | 60.32 | |
| 128 | Probiotics and Antimicrobial Proteins | journal | 0.509 Q3 | 52 | 32 | 85 | 1356 | 143 | 84 | 1.36 | 42.38 | |
| 127 | Acta Naturae | journal | 0.658 Q3 | 36 | 62 | 91 | 2791 | 174 | 84 | 1.91 | 45.02 |  |
| 126 | Drug Discovery Today: Disease Models | journal | 0.310 Q4 | 33 | 22 | 93 | 1027 | 56 | 82 | 0.63 | 46.68 | |
| 125 | Current Cancer Therapy Reviews | journal | 0.159 Q4 | 17 | 31 | 94 | 1962 | 33 | 86 | 0.33 | 63.29 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data